We would love to hear your thoughts about our site and services, please take our survey here.
Making noise is important, also, shorters will eventually shoot themselves in the foot with this share. Fundamentals are very strong (this is my opinion, obvs) so I'm DCA'ing in and have no rush
"Application will be made to the London Stock Exchange to admit the 37,500,000 new ordinary shares to trading on AIM. Admission of the new ordinary shares is expected to occur on or around 18 June 2020. The new ordinary shares will rank pari passu with the existing ordinary shares."
So they expect to raise almost a 20% of the total market cap, around 18 June 2020
The "placebo" is now a wrong choice of a name for a thing that is not a placebo (i.e. its effect can't be explained by the placebo effect) plus it has a patent application being processed. Regarding the product cream, there should have been news but the covid-19 probably affected the deadlines they had set with their potential partner and hence no decision made on it, AFAIK
They haven't even finished the trial, see latest RNS
check the long term share price, you'll understand
I've been watching this form the sidelines, is this RNS the "design freeze"? I see no mention on it of having reached such stage but please correct me if I'm wrong
I'm pondering about the case with PMs, I'm bullish on Silver but prefer a mining stock like this than the actual metal
Looks to me like there's a lot of interest in this share and investors are eager for the design freeze RNS only that the wait is getting longer than I expected
CEO said transformative because there's so much cash on the bank right now the company will use it to grow and expand the business, tens of millions in profit in just a matter of months. Plenty of money to invest, acquire other business, who knows. This is more of a long term play IMO than quick multibagger (I could be wrong if the US sales or other unexpected news come up)
Because it's not a placebo, its effect can't be explained by the placebo effect. It beat a competitor (vitaros) which in turn beat a true placebo, ergo dermasys works. It's comparable to low doses of cialis, read on the web. They have filed a patent for the formulation